These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21425987)

  • 1. Inhibitors of translation initiation as cancer therapeutics.
    Lindqvist L; Pelletier J
    Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stopping trouble before it starts.
    Clardy J
    ACS Chem Biol; 2006 Feb; 1(1):17-9. PubMed ID: 17163634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of small molecules targeting eIF4A.
    Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
    RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
    Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
    Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.
    Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Merrick WC; Romo D; Liu JO
    Mol Cell; 2005 Dec; 20(5):709-22. PubMed ID: 16337595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
    Shen L; Pelletier J
    Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity.
    Low WK; Dang Y; Bhat S; Romo D; Liu JO
    Chem Biol; 2007 Jun; 14(6):715-27. PubMed ID: 17584618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A.
    Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Rzasa RM; Shea HA; Li S; Park K; Ma G; Romo D; Liu JO
    Methods Enzymol; 2007; 431():303-24. PubMed ID: 17923240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting translation: eIF4E as an emerging anticancer drug target.
    Lu C; Makala L; Wu D; Cai Y
    Expert Rev Mol Med; 2016 Jan; 18():e2. PubMed ID: 26775675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
    Raza F; Waldron JA; Quesne JL
    Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication.
    Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational dysregulation by Pateamine A.
    Korneeva NL
    Chem Biol; 2007 Jan; 14(1):5-7. PubMed ID: 17254945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kappaB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer.
    Giri RS; Thaker HM; Giordano T; Chen B; Nuthalapaty S; Vasu KK; Sudarsanam V
    Eur J Med Chem; 2010 Sep; 45(9):3558-63. PubMed ID: 20557982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of translation targeting eukaryotic translation initiation factor 4A.
    Cencic R; Galicia-Vázquez G; Pelletier J
    Methods Enzymol; 2012; 511():437-61. PubMed ID: 22713332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
    Bordeleau ME; Matthews J; Wojnar JM; Lindqvist L; Novac O; Jankowsky E; Sonenberg N; Northcote P; Teesdale-Spittle P; Pelletier J
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10460-5. PubMed ID: 16030146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation initiation: a critical signalling node in cancer.
    Robert F; Pelletier J
    Expert Opin Ther Targets; 2009 Nov; 13(11):1279-93. PubMed ID: 19705976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA).
    Kommaraju SS; Aulicino J; Gobbooru S; Li J; Zhu M; Romo D; Low WK
    Biochem Cell Biol; 2020 Aug; 98(4):502-510. PubMed ID: 32008367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A.
    Bordeleau ME; Mori A; Oberer M; Lindqvist L; Chard LS; Higa T; Belsham GJ; Wagner G; Tanaka J; Pelletier J
    Nat Chem Biol; 2006 Apr; 2(4):213-20. PubMed ID: 16532013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
    Walsh D
    Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.